Vibrant Therapeutics, a clinical-stage biotechnology company specialising in intelligent therapeutics, has appointed Han Lee ...

The financing includes new investors Pfizer Ventures and Apricot Capital, bringing the total capital raised to $100m ...

For decades, pharma communications spoke the language of health systems, designed to inform healthcare professionals, ...

Learn how a next-generation approach to field training – powered by Generative AI (GenAI) and lifelike avatar simulations and ...

NanoSyrinx has announced the appointment of Thomas J Farrell as its new CEO.

Takeda’s zasocitinib has shown strong rates of skin clearance, as well as other benefits, in new study results regarding ...